Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Ekso Bionics Holdings, Inc. (EKSO : NSDQ)
 
 • Company Description   
Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.

Number of Employees: 66

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.35 Daily Weekly Monthly
20 Day Moving Average: 265,056 shares
Shares Outstanding: 2.35 (millions)
Market Capitalization: $7.89 (millions)
Beta: 0.95
52 Week High: $22.95
52 Week Low: $2.73
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.01% -29.14%
12 Week -40.89% -51.41%
Year To Date -63.37% -65.10%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
101 GLACIER POINT SUITE A
-
SAN RAFAEL,CA 94901
USA		 ph: 510-984-1761
fax: 510-927-2647		 investors@eksobionics.com http://www.eksobionics.com
 
 • General Corporate Information   
Officers
Scott G. Davis - Chief Executive Officer
Jerome Wong - Chief Financial Officer
Mary Ann Cloyd - Director
Corinna Lathan, - Director
Charles Li - Director

Peer Information
Ekso Bionics Holdings, Inc. (ABMD)
Ekso Bionics Holdings, Inc. (DMDS)
Ekso Bionics Holdings, Inc. (CPWY.)
Ekso Bionics Holdings, Inc. (EQUR)
Ekso Bionics Holdings, Inc. (ECIA)
Ekso Bionics Holdings, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 282644400
SIC: 3569
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 2.35
Most Recent Split Date: 6.00 (0.07:1)
Beta: 0.95
Market Capitalization: $7.89 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.20 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-5.10 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.51
Price/Cash Flow: -
Price / Sales: 0.45
EPS Growth
vs. Year Ago Period: 40.00%
vs. Previous Quarter: 14.29%
Sales Growth
vs. Year Ago Period: -10.14%
vs. Previous Quarter: -33.69%
ROE
03/31/25 - -82.50
12/31/24 - -84.42
09/30/24 - -83.09
ROA
03/31/25 - -39.19
12/31/24 - -40.54
09/30/24 - -39.03
Current Ratio
03/31/25 - 2.35
12/31/24 - 2.50
09/30/24 - 2.81
Quick Ratio
03/31/25 - 1.77
12/31/24 - 1.89
09/30/24 - 2.14
Operating Margin
03/31/25 - -61.51
12/31/24 - -63.21
09/30/24 - -62.95
Net Margin
03/31/25 - -61.51
12/31/24 - -63.21
09/30/24 - -62.95
Pre-Tax Margin
03/31/25 - -61.51
12/31/24 - -63.21
09/30/24 - -62.95
Book Value
03/31/25 - 6.56
12/31/24 - 8.66
09/30/24 - 10.13
Inventory Turnover
03/31/25 - 1.67
12/31/24 - 1.71
09/30/24 - 1.69
Debt-to-Equity
03/31/25 - 0.28
12/31/24 - 0.30
09/30/24 - 0.28
Debt-to-Capital
03/31/25 - 22.08
12/31/24 - 23.27
09/30/24 - 21.64
 

Powered by Zacks Investment Research ©